Polonsky WH, Giorgino F, Rosenstock J, Whitmire K, et al. Improved patient-reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial. Diabetes Obes Metab 2022 Aug 23. doi: 10.1111/dom.14822.
PMID: 36053820